Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, Australia.
Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):671-680. doi: 10.1158/1055-9965.EPI-23-0813.
Digital mammography has replaced film mammography in breast-screening programs globally, including Australia. This led to an increase in the rate of detection, but whether there was increased detection of clinically important cancers is uncertain.
In this population-wide retrospective cohort study in New South Wales, Australia spanning 2004 to 2016 and including 4,631,656 screens, there were 22,965 cancers in women screened with film (n = 11,040) or digital mammography (n = 11,925). We examined the change in tumor characteristics overall and how these rates changed over time, accounting for changes in background rates using an interrupted time-series. Comparisons were made with unscreened women (n = 26,326) during this time.
We found increased detection of in situ cancer (3.36 per 10,000 screens), localized invasive, and smaller-sized breast cancers attributable to the change in mammography technology, whereas screen-detected intermediate-sized and metastatic breast cancers decreased. Rates of early-stage and intermediate-sized interval cancers increased, and late-stage (-1.62 per 10,000 screens) and large interval cancers decreased. In unscreened women, there were small increases in the temporal trends of cancers across all stages.
At least some of the increased detection of smaller early-stage cancers may have translated into a reduction in larger and late-stage cancers, indicating beneficial detection of cancers that would have otherwise progressed. However, the increased detection of smaller early-stage and small cancers may also have increased over-diagnosis of lesions that would otherwise have not caused harm.
Robust evaluation of potential benefits and harms is needed after changes to screening programs. See related In the Spotlight, p. 638.
数字乳腺 X 线摄影已在全球范围内的乳腺筛查项目中取代了胶片乳腺 X 线摄影,包括澳大利亚。这导致了检出率的提高,但检出的临床重要癌症是否增加尚不确定。
在这项澳大利亚新南威尔士州的人群回顾性队列研究中,研究时间跨度为 2004 年至 2016 年,共纳入了 4631656 次筛查,其中 22965 例女性被诊断为癌症,这些女性接受的筛查方式为胶片乳腺 X 线摄影(n=11040)或数字乳腺 X 线摄影(n=11925)。我们总体上检查了肿瘤特征的变化,以及随着时间的推移这些变化的变化率,通过中断时间序列分析考虑了背景率的变化。在此期间,还与未筛查的女性(n=26326)进行了比较。
我们发现,由于乳腺摄影技术的变化,原位癌(每 10000 次筛查中增加 3.36 例)、局限性浸润性和较小的乳腺癌的检出率增加,而筛查发现的中等大小和转移性乳腺癌的检出率下降。早期和中等大小的间隔期癌症的发生率增加,晚期(每 10000 次筛查减少 1.62 例)和大间隔期癌症减少。在未筛查的女性中,所有阶段的癌症随时间推移的趋势都有微小的增加。
较小的早期癌症的检出率增加至少有一部分可能转化为较大和晚期癌症的减少,这表明对可能进展的癌症进行了有益的检测。然而,较小的早期和小癌症的检出率增加也可能增加了对否则不会造成伤害的病变的过度诊断。
在筛查项目发生变化后,需要对潜在的益处和危害进行严格评估。参见相关的特写文章,第 638 页。